Идёт набор NCT06989775

BoxX-NoAF Clinical Trial

Без фазы С лечением Post Operative Atrial Fibrillation Atrial Fibrillation, Postoperative

Ориентир для пациента и семьи

Простыми словами

Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.

Что изучают: В протоколе указаны: Isolator® Synergy™ EnCompass® Ablation System and AtriClip® LAA Exclusion System.
Кому может быть актуально: Состояния в реестре: Post Operative Atrial Fibrillation, Atrial Fibrillation, Postoperative. Базовые параметры: от 65 лет · Все.
Что важно проверить: Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
Где проводится: США, Канада
Следующий шаг: Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →

Не всё понятно в терминах? Прочитайте наш гид для пациентов →

Официальное название

EnCompass Clamp and the AtriClip in Box Lesion and Left Atrial Appendage EXclusion Procedure for the Prevention of New Onset of Atrial Fibrillation

Обзор

Post Operative Atrial Fibrillation (POAF) is the most common complication of cardiac surgery. POAF incidence can exceed 50% depending on the patient baseline characteristics and surgery type. Patients with POAF tend to have worse acute and long-term clinical outcomes. BoxX-NoAF is a randomized trial to evaluate if prophylactic ablation and exclusion of the Left Atrial Appendage at the time of other routine cardiac surgery can reduce the incidence of post operative AF and clinical AF during long term follow up in patients who have not yet developed AF but are at risk.

Вмешательства

Устройство Isolator® Synergy™ EnCompass® Ablation System and AtriClip® LAA Exclusion System
Box lesion ablation with the Isolator Synergy EnCompass Clamp System and LAAE using the AtriClip LAA Exclusion System at the time of planned cardiac surgery

Первичные конечные точки

Primary Effectiveness Endpoint [Срок оценки: 30 days post index cardiac surgical procedure]
Primary Safety Endpoint [Срок оценки: 30 days post index cardiac surgical procedure]

Вторичные конечные точки (1)

Powered Secondary Effectiveness Endpoint [Срок оценки: 3 years post index cardiac surgical procedure]

Критерии участия

Критерии включения

Planned and clinically indicated for cardiac surgical procedure requiring cardiac bypass and opening of the pericardium
Age ≥ 65 years and CHA2DS2-VASc ≥ 3

Критерии исключения

Documented history of atrial fibrillation or atrial flutter anytime prior to the cardiac surgery
Prior procedure involving opening the pericardium or entering the pericardial space
Patients undergoing off-pump surgery
Prior LAA occlusion, exclusion, or removal (surgical or percutaneous)
Presence of a permanent pacemaker
Infiltrative cardiomyopathies (i.e. amyloidosis)
Planned cardiac surgical procedure using non-sternotomy approaches
Patients whose planned procedure is a heart transplant or implantation of any long-term ventricular assist devices
Presence of ventricular arrhythmia
Active endocarditis
NYHA Class IV heart failure symptoms
Preoperative need for an intra-aortic ballon pump or intravenous inotropes
Active systemic infection at the time of cardiac surgery requiring antibiotics
Known allergy to Nitinol or nickel sensitivity
Known medical condition with expected survival of less than 1 year
Other comorbidities that in the Investigator's opinion make the subject unsuitable candidate to complete the protocol required intervention or visits
Current enrollment in an investigation or trial or an investigational devices or investigational drug that would interfere with this trial
Mental impairment or other psychiatric conditions which may not allow the patient to understand the nature, significance, and scope of the trial.
Pregnancy
Known severe symptomatic carotid disease